Akebia Therapeutics Announces Participation in Upcoming Investor Conferences

CAMBRIDGE, Mass.: CAMBRIDGE, Mass., Nov. 24, 2021 /PRNewswire/ — Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John P. Butler, Chief Executive Officer, and David A. Spellman, Chief Financial Officer, will participate in the following investor conferences: Piper Sandler 33rd Annual Virtual Healthcare ConferenceNovember 29 – December 2, 2021 John Butler will participate in a virtual fireside chat, which will be available on the conference site prior to the virtual event.
Click here to view original post